87679-71-8C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21AHYHTSYNOHNUSH-HXFGRODQSA-NTrandolaprilat is a heterobicyclic compound that is trandolapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of the prodrug trandolapril. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent, a drug metabolite and a human xenobiotic metabolite. It is a tertiary carboxamide, an organic heterobicyclic compound, a dicarboxylic acid, a dipeptide and a secondary amino compound.
化学的特性Pale Yellow Solid
Warning
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P260, P280, P318, P319, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 42 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
RR6866VL0O
TRANDOLAPRILAT
Established Pharmacologic Class [EPC] - Angiotensin Converting Enzyme Inhibitor
Mechanisms of Action [MoA] - Angiotensin-converting Enzyme Inhibitors
Trandolaprilat is an Angiotensin Converting Enzyme Inhibitor. The mechanism of action of trandolaprilat is as an Angiotensin-converting Enzyme Inhibitor.
使用Trandolaprilat (Trandolapril EP Impurity E) is a metabolite of Trandolapril (T713500), an antihypertensive. Angiotensin converting enzyme (ACE) inhibitor.
読み込み中…
87679-71-8DTXSID101024709CHEMBL1201387CHEBI:141521